What is Reveri?
Founded in 2020 by Dr. David Spiegel, a preeminent authority in psychiatry and behavioral sciences at Stanford University, and serial entrepreneur Ariel Poler, Reveri offers a sophisticated self-hypnosis application designed to facilitate cognitive and behavioral change. The platform distinguishes itself from generic wellness apps by grounding its methodology in rigorous clinical experience and scientific validation. By focusing on human augmentation, Reveri addresses critical gaps in traditional mental health care, offering users a ten-minute, accessible pathway to improved psychological resilience and habit formation. The company operates at the nexus of digital therapeutics and consumer health, targeting a broad demographic seeking non-pharmacological alternatives for stress and pain management.
How much funding has Reveri raised?
Reveri has raised a total of $1.8M across 1 funding round:
Angel/Seed
$1.8M
Angel/Seed (2022): $1.8M with participation from Background Capital, Bobby Lo, and InReach Ventures
Key Investors in Reveri
InReach Ventures
InReach Ventures is an AI-powered venture capital firm that specializes in discovering and investing in early-stage startups across Europe. Utilizing proprietary software known as DIG, the firm evaluates and supports promising business ideas and founding teams.
Background Capital
A venture firm focused on supporting early-stage technology companies with high growth potential and innovative business models.
Bobby Lo
An active angel investor and entrepreneur with a focus on supporting disruptive technology startups and human-centric digital platforms.
What's next for Reveri?
With this major enterprise-level funding, Reveri is poised to accelerate its product development roadmap and expand its reach within the competitive digital health landscape. The strategic capital will likely be deployed to enhance the platform's proprietary algorithms, broaden its clinical content library, and scale user acquisition efforts. As the company transitions from its initial growth phase, the focus will shift toward establishing deeper partnerships within the healthcare ecosystem and solidifying its brand as the gold standard for evidence-based self-hypnosis. Investors are closely watching how Reveri leverages its unique combination of academic prestige and entrepreneurial agility to capture a larger share of the burgeoning mental wellness market.
See full Reveri company page
